Anteris Technologies Global Corp. Share Price
AVRAnteris Technologies Global Corp. Stock Performance
Open $6.08 | Prev. Close $5.96 | Circuit Range N/A |
Day Range $5.99 - $6.13 | Year Range $2.71 - $6.92 | Volume 47,846 |
Average Traded $6.05 |
Anteris Technologies Global Corp. Share Price Chart
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Apr-26 | $6.08 | $6.11 | +0.00% |
17-Apr-26 | $6.08 | $6.11 | -2.94% |
15-Apr-26 | $6.24 | $6.29 | +0.00% |
14-Apr-26 | $6.28 | $6.29 | +1.70% |
13-Apr-26 | $5.67 | $6.18 | +8.51% |
10-Apr-26 | $5.58 | $5.70 | +3.35% |
09-Apr-26 | $5.35 | $5.51 | +1.19% |